Chengdu Hyperway Pharmaceuticals is a startup biotech company founded in January 2019 by a group of high caliper biotech entrepreneurs and industry veterans, located in Chengdu high tech Development Zone. Hyperway adheres to the concept of "embracing all rivers, absorbing all strengths, benefiting the people all over the world and making great achievements", and is committed to discover and develop new medicines to address unmet medical needs using breakthroughs in science and technology.


Hyperway has growth rapidly since its incorporation. Hyperway has attracted many talents worldwide in building a world class R&D team and scientific advisory team. Our core team members have many years of scientific and management experience in leading global or domestic pharmaceutical companies, such as Bayer, Sanofi, Merck, Wuxi PharmaTech, ChemPartner and Amgen. Among their achievements, some are inventers of several first in class new drug candidates that are being evaluated in clinical trials. Our scientific advisory team composes some most respected scientists and experts in pharmaceutical industry.


Within a short period of time, we have developed an impressive pipeline cover many therapeutic areas, including oncology, pain and CNS. Most of them are still in early development stages of course.


We are confident that with our determination and expertise we will be successful in discovering, developing and commercializing pharmaceuticals to serve patients worldwide.